The global dry eye syndrome market size was worth USD 4.26 Billion in 2024. The market is further expected to grow at a CAGR of 6.80% between 2025 and 2034 to reach a value of approximately USD 8.22 Billion by 2034.
Base Year
Historical Year
Forecast Year
Value in USD Billion
2025-2034
Dry Eye Syndrome Market Outlook
*this image is indicative*
The R&D partnership and the Choice and Lice agreement for the development of gene therapy vectors for retinal diseases were concluded in June 2020 with Santen Pharmaceutical Co., Ltd. and Oxford Biomedica. This R&D partnership primarily aims to produce pre-clinical evidence for OXB's idea for the treatment of inherited retinal diseases using lentiviral vectors. This will support the company's product growth, which will also aid the growth of the overall market.
Dry eye syndrome, scientifically identified as keratoconjunctivitis sicca (KCS), refers to a distinguishing concept of the person's eye surface that lacks lubrication or moisture. It is a severe disease that can affect virtually everyone. Several dry eye signs include nausea and burning sensations, eyes swollen, red eyes, fatigued eyes, itchy eyes, and photophobia, among others. In addition, watery eyes may also be a symptom, as a dry eye surface over-stimulates the development of watery tears to alleviate the dryness. Dry eye disease can be caused by excessive use of computers, allergies, obesity, menopause, smoking, LASIK eye surgery, and hormone replacement therapy, among others.
Based on disease type, the market is divided into the following:
Based on drug type, the market can be divided into the following:
On the basis of product, the industry can be segmented into:
Based on distribution channel, the market can be divided into the following:
On the basis of region, the industry can be segmented into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of the global dry eye syndrome market is largely due to the rise in the widespread occurrence of dry eye syndrome, which is attributed to a variety of factors. The increasing geriatric population around the world has resulted in a rise in the incidence of the syndrome because tear glands weaken because of their ageing and cannot produce enough tear fluid to hold a lubricating film on the eyes. Another key factor for the rising incidence of dry eye syndrome is the higher prevalence of other conditions, which can affect the functioning of the eye like diabetes. The changes in patient's blood composition due to diabetes will adversely affect the weeping glands, causing dry eye syndrome. Many diseases that can cause dry-eye syndrome indirectly include vitamin A deficiency, lupus, thyroid disease, and rheumatoid arthritis. The growing occurrence of such diseases in the market is expected to aid the overall market growth.
The report gives a detailed analysis of the following key players in the global dry eye syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is projected to grow at a CAGR of 6.80% between 2025 and 2034.
The market is estimated to witness a healthy growth in the forecast period of 2025-2034 to reach about USD 8.22 Billion by 2034.
The major drivers of the market are the rising occurrence of dry eye syndrome, and changing lifestyles.
The key trends guiding the growth of the market include the rising research and development activities in the industry and increasing geriatric population.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Evaporative and aqueous dry eye syndromes are the major disease types in the market.
Anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops are the major drug types in the market.
Liquid drops, gel, liquid wipes, and eye ointment, among others, are the major products in the market.
The major distribution channels in the market are hospital pharmacies, retail pharmacies, and online pharmacies.
The major players in the global dry eye syndrome market are Akorn, Incorporated., AbbVie, Auven Therapeutics, Nicox S.A., and Novartis AG, among others.
In 2024, the global dry eye syndrome market attained a value of nearly USD 4.26 Billion.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by Product |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share